MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-50-0050815
Nortis Biotech Private Limited
Nortis Biotech Private Limited - pharma in Mohanlalganj, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.08 Cr
▲ 16% YoY
Net profit · FY 2025
₹4.58 Lakh
Net margin 4.2%
EBITDA · FY 2025
₹10.86 Lakh
EBITDA margin 10.1%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Nortis Biotech Private Limited
Data last updated:
Nortis Biotech Private Limited is a private limited company based in Mohanlalganj, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 November 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U33309UP2017PTC098997. Its GSTIN is 09AAFCN8546C1ZB (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Neelam Singh and Ayushi Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mohanlalganj, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.08 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹4.58 Lakh (net margin 4.2%) and EBITDA of ₹10.86 Lakh (EBITDA margin 10.1%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 6% over five years.
Nortis Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0050815). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Nortis Biotech Private Limited
CIN U33309UP2017PTC098997
Registration Number 098997
Incorporation Date 30 November 2017
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-50-0050815
Recognitions & Rankings of Nortis Biotech
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressKh No 154 Birura Kalli Paschim, Raebareli Road, Mohanlalganj, Uttar Pradesh, India – 226301
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Nortis Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Nortis Biotech Private Limited
The main business activity of Nortis Biotech is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nortis Biotech Private Limited FY 2025 filings available
Nortis Biotech Private Limited reported revenue of ₹1.08 Cr (up 16% YoY) for FY 2025.
Revenue · FY 2025
₹1.08 Cr ▲ 16%
Net profit · FY 2025
₹4.58 Lakh margin 4.2%
EBITDA · FY 2025
₹10.86 Lakh margin 10.1%
Compounded Annual Growth Rate (CAGR) of Nortis Biotech Private Limited
Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▼ 1%
5 years · compounded
▼ 6%
EBITDA CAGR growth
1 year
▼ 17%
3 years · compounded
▲ 30%
5 years · compounded
▲ 7%
Revenue rose 16% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 6%. EBITDA fell 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nortis Biotech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹10.86 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.58 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nortis Biotech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nortis Biotech are in the company report.
Premium access
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Nortis Biotech Private Limited
Nortis Biotech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ayushi Singh | Additional Director | 19 Dec 2019 | 6 Years 10 Months | Current |
| Neelam Singh | Director | 30 Nov 2017 | 8 Years 10 Months | Current |
Peer Comparison of Nortis Biotech Private Limited
Nortis Biotech Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dominant Pharma Private Limited | ₹1.08 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Vadodara, Gujarat, India |
| Vyankatesh Medicare Private Limited | ₹1.08 Cr (FY 2025) | •••• | •••• | -27.0% | •••• | Nagpur, Maharashtra, India |
| Chaplet Pharmaceutical Private Limited | ₹1.08 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | New Delhi, Delhi, India |
| Masttree Formulations Private Limited | ₹1.08 Cr (FY 2024) | •••• | •••• | 178.0% | •••• | Lucknow, Uttar Pradesh, India |
| Vispa Biotech Private Limited | ₹1.08 Cr (FY 2025) | •••• | •••• | 260.0% | •••• | Navi Mumbai, Maharashtra, India |
| Nortis Biotech Private Limited this company | ₹1.08 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Mohanlalganj, Uttar Pradesh, India |
| Kinegic Pharmaceuticals Private Limited | ₹1.08 Cr (FY 2022) | •••• | •••• | 115.0% | •••• | Hyderabad, Telangana, India |
| Alliswell Biohealth Private Limited | ₹1.07 Cr (FY 2021) | •••• | •••• | 6.0% | •••• | New Delhi, Delhi, India |
| Medswap Pharmaceuticals Private Limited | ₹1.07 Cr (FY 2024) | •••• | •••• | 20.0% | •••• | Kolhapur, Maharashtra, India |
| Ornate Pharma Pvt Ltd | ₹1.07 Cr (FY 2025) | •••• | •••• | -47.0% | •••• | Sanand, Gujarat, India |
| Trubeca Lifesciences Private Limited | ₹1.07 Cr (FY 2025) | •••• | •••• | 38.0% | •••• | Zirakpur, Punjab, India |
Peers are the five companies nearest above and the five nearest below Nortis Biotech by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Nortis Biotech Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nortis Biotech Private Limited
Nortis Biotech Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Nortis Biotech Private Limited
Employment history and EPFO contributions of people linked to Nortis Biotech.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Nortis Biotech Private Limited
Nortis Biotech Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Arvind Kumar Singh ceased to be Director on 19 Dec 2019.
AGM
Nortis Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nortis Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Ceased
Arvind Kumar Singh ceased to be Director.
Appointed
Ayushi Singh was appointed as Additional Director.
Appointed
Neelam Singh was appointed as Director.
Incorporation
30 Nov 2017
Nortis Biotech Private Limited was registered on 30 Nov 2017 with Roc Kanpur & aged 8 years 10 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Nortis Biotech Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nortis Biotech Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nortis Biotech Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nortis Biotech Private Limited
Nortis Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCN8546C1ZB | Uttar Pradesh | Active | 28 Nov 2018 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nortis Biotech Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nortis Biotech Private Limited
Nortis Biotech is an active private limited company based in Mohanlalganj, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 November 2017 (9+ years old) and is registered under CIN U33309UP2017PTC098997.
Nortis Biotech reported revenue of ₹1.08 Cr for FY 2025 (up 16% YoY).
Nortis Biotech has 2 current directors:
- Ayushi Singh - Additional Director
- Neelam Singh - Director
Nortis Biotech reported a net profit of ₹4.58 Lakh (net margin 4.2%) and EBITDA of ₹10.86 Lakh (EBITDA margin 10.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nortis Biotech is -1% over three years and -6% over five years. In the latest year (FY 2025) revenue rose 16%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nortis Biotech is 09AAFCN8546C1ZB, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Nortis Biotech is U33309UP2017PTC098997. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nortis Biotech was incorporated on 30 November 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Nortis Biotech by revenue are Dominant Pharma Private Limited, Vyankatesh Medicare Private Limited, Chaplet Pharmaceutical Private Limited, Masttree Formulations Private Limited, Vispa Biotech Private Limited and 5 more, all in the Pharma industry (Formulations).
Arvind Kumar Singh ceased to be Director on 19 Dec 2019. Ayushi Singh was appointed as Additional Director on 19 Dec 2019. Neelam Singh was appointed as Director on 30 Nov 2017.
Yes, Nortis Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0050815).